SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Omeros
An SI Board Since March 2010
Posts SubjectMarks Bans Symbol
464 28 0 OMER
Emcee:  Bradpalm1 Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
264Information we know ........ just added exposure ... ***************************Howard Williams-11/13/2014
263>>$165 production cost per vial is high. If it's $65 I'd bet it&#Biomaven-11/12/2014
262You're on the right track Bulba, but I think your $165 production cost per vHoward Williams-11/12/2014
261Thanks Harold. So is it your understanding that the Omeros gross profit on OmidrBulbaMan-11/12/2014
260Bulba, that would be nice to know but OMER has consistently steered clear of proHoward Williams-11/12/2014
259Howard: Re pass-through reimbursement, in the CC Omeros CEO Gregory Demopulos stBulbaMan-11/12/2014
258And then there's OMS103 ...... On their website and in yesterday's 10-QHoward Williams-11/11/2014
257I think the volume today suggest more than short covering - someone wanted some Steve Lokness-11/11/2014
256Omidria rollout tea leaves inVentiv's initial 20 dedicated Omidria sales repHoward Williams-11/11/2014
255Omeros Corporation Reports Third Quarter 2014 Financial Results [and Omidria $46Howard Williams-11/10/2014
254 Omeros Announces Positive Data for MASP-2 Inhibitor in Experimental Model of StHoward Williams-11/6/2014
253Omeros Corporation to Announce Third Quarter 2014 Financial Results on November Howard Williams-11/4/2014
252IMO Omidria will become the standard of care now that it has approved reimbursemHoward Williams-10/31/2014
251Four analyst updates ........ thumbs up ************************************* WHoward Williams-10/30/2014
250I'm going to take credit for the move today. For technical reasons I sold a Steve Lokness-10/30/2014
249 Omidria™ Granted Pass-Through Reimbursement Status from CMS -- Unique Billing CHoward Williams-10/30/2014
248 Omeros to Present at the Wedbush PacGrow 2014 Life Sciences Management Access CHoward Williams-8/8/2014
247OMER's short interest dropped just over 150,000 shares during the second halHoward Williams-7/14/2014
246New/good SeekingAlpha article out on OMER seekingalpha.com SummaryCommentary oHoward Williams-6/25/2014
245OMER is clearly breaking out here. Interestingly, the 6/13 short position was aHoward Williams-6/25/2014
244Some thoughts about European Omidria partnering After listening to the OMER repHoward Williams-6/12/2014
243New all time high intraday today ......... :-)Howard Williams-6/10/2014
242Driver for OMER's $2 rise since Wednesday morning? *************************Howard Williams-6/6/2014
241WBB Securities .... OMER update report yesterday 6/3/14 DOUBLES one-year priceHoward Williams-6/4/2014
240Looks like good news to me...and the really interesting part of the pipeline stifred hayes-6/2/2014
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News